RxDoctor Payments Data

Navin Gupta, DPM

Podiatrist · West Des Moines, IANPI 1659378917

Payments from drug & device makers

What this record shows

Convatec Inc. accounts for 94.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $1,962 and has fallen 91.7% since, to $162 in 2025.

$2,196in general payments, 2019–2025

Across 25 payments — averaging $87.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$2K
  • Amgen$47
  • Abiomed$22
  • Kerecis Limited$18
  • Smith+Nephew$17
  • Surgenex LLC$15

What the payments were for

  • Travel & lodging$1,18354%
  • Food & beverage$1,01346%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Convatec Inc.18$2,077
Amgen(2 entities)3$47
Abiomed1$22
Kerecis Limited1$18
Smith+Nephew1$17
Surgenex LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,196 in reported general payments places this provider in the 55th percentile of 94 podiatrist providers in Iowa.

See all podiatrist providers in Iowa

Medicare billing

Part B allowed, 2024
$367,062
Medicare patients
249
Services billed
1,856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate12$130

Paid to pharmacies, not to this prescriber.

Other podiatrist in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →